Thymogen

Thymus & immune system Approved · Russia Human trials Synthetic short peptide (Cytogen)

Also called Thymagen, Oglufanide, EW dipeptide

A two-amino-acid peptide first isolated from calf thymus extract and now made synthetically. It is the most clinically used of this family, given to support immune recovery during infections and after surgery or radiation.

Why people take it

Immune recovery during infectionPost-surgical recoveryHepatitis support

What studies report

Worth knowing: The most clinically used of this family, but the trials are Russian and mostly older.

Status: Registered medicine in Russia. Not approved in the US or EU.

Route
Subcutaneous injection, or oral capsule depending on the preparation
Sequence
Glu-Trp
Formula
C16H19N3O5
Molecular weight
333.34 g/mol
CAS
38101-59-6
Available as
1 mg
View on PubChem →

Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.